NIH-funded research R01 grant

Improving surgical training for benign urological procedures using AI feedback

Official title: Assessing, Optimizing, and Delivering Surgical Feedback with AI for Benign Urological Robotic Surgeries

Funded at Cedars-Sinai Medical Center · NIH-11028231 · Data updated 2026-11-12

This study is all about helping new surgeons get better at performing robotic surgeries for non-cancerous urological issues by using smart technology to give them helpful feedback during their training, making the whole process faster and safer for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startDecember 1, 2024
Project endNovember 30, 2029
Funding year2025
Award (this year)$596,179
NIH project number1R01CA298988-01
Project IDNIH-11028231 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients undergoing benign urological robotic surgeries.

Less likely to help

Patients who are not undergoing benign urological surgeries or those who are not involved in surgical training may not benefit from this research.

What this research studies

This research focuses on enhancing the training of surgeons performing benign urological robotic surgeries by providing consistent and effective feedback. It aims to assess the current feedback exchange during surgical training and develop methods to optimize this process using artificial intelligence. By analyzing 500 training cases across multiple medical centers, the study will categorize feedback and create AI tools to deliver real-time, video-based feedback to novice surgeons. This approach seeks to shorten the learning curve and improve surgical outcomes for patients.

Why it matters

Potential benefit: If successful, this research could lead to better-trained surgeons, resulting in improved patient outcomes and reduced complications during benign urological surgeries.

How similar studies have gone: Previous research has shown that structured feedback and AI-assisted training can significantly enhance surgical skills, indicating a promising approach in this area.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Hung, Andrew — Cedars-Sinai Medical Center
  • Study coordinator: Hung, Andrew

Related research

Other NIH-funded projects on the same topics.

  • Lipid signals that control acetyl-CoA and fat metabolism in NAFLD

    A study exploring how membrane lipids influence acetyl-CoA metabolism to understand and potentially treat nonalcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591466

  • Them1’s role in fat metabolism and MASLD progression

    Aims to understand how a fat-regulating protein (Them1) affects energy use in fat and liver, and how this could contribute to MASLD in people who are overweight.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591395

  • Biomarker-guided Immunosuppression in Kidney Transplant Patients

    A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11550940

  • Alpha5 integrin's role in ALS: how a cell switch worsens disease

    Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11540166

  • Chlamydia pneumoniae infection and Alzheimer's disease progression

    This project looks at whether a common lung infection, Chlamydia pneumoniae, might influence Alzheimer's disease in people and what that could mean for treatment.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11538116

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.